<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Treatment of COVID-19 is a major challenge for health care settings because no antiviral therapies of proven efficacy are available yet due to insufficient data on disease pathogenesis. Due to lack of proper medication, several options including vaccines, monoclonal antibodies, peptides, interferon and oligonucleotide based therapies have been used to cure patients [
 <xref ref-type="bibr" rid="CR18">18</xref>]. In the beginning of epidemics, antiviral treatments such as lopinavir and ritonavir oseltamivir and ganciclovir along with corticosteroids were used that already were practiced in SARS and MERS cases but as per WHO interim guideline corticosteroid treatment was discontinue due to prompted lung injury or shock [
 <xref ref-type="bibr" rid="CR22">22</xref>]. In addition, antibacterial including moxifloxacin, ceftriaxone, azithromycin and glucocorticoid therapy have been used because vaccine preparation will take more than year as per WHO thus supportive and personal care options are in practice to minimize effects of deadly COVID-19.
</p>
